Clustering data with hclust algorithm for Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma (Study ST000916)

Core G Fatty acids/Eicosanoids (Analysis AN001491)
MetaboliteStructureF1F2F3F4
FA(22:3)ME2315110.552.750.230.99
20oh PGE2ME2314490.320.801.071.53
2,3 dinor TXB2ME2314870.650.711.381.32
FA(26:0)ME2315190.401.480.571.66
10 HDoHEME2314651.001.540.550.81
16 HDoHEME2314550.871.520.820.83
12-HEPEME2314680.431.510.881.28
12-HETEME2314670.491.510.781.40
12-HHTrEME2314520.481.411.031.08
11 HDoHEME2314700.621.420.831.09
PGE2ME2314450.571.470.911.12
FA(23:0)ME2315160.661.750.681.11
14 HDoHEME2314690.421.830.800.96
TxB2ME2314440.331.660.941.03
FA(22:1)ME2315091.181.330.621.09
FA(18:4)ME2314991.241.110.910.73
11-HETEME2314531.301.080.810.89
18-HETEME2314751.330.940.820.88
13-HOTrEME2314621.401.210.720.72
FA(22:2)ME2315101.371.190.670.95
HXB3ME2314720.751.210.741.36
FA(22:0)ME2315080.791.240.871.20
FA(24:0)ME2315170.921.270.791.16
FA(22:4)ME2315121.200.960.881.03
dhk PGD2ME2314481.141.040.841.07
FA(24:1)ME2315181.200.990.831.09
FA(18:1)ME2314951.051.090.940.93
FA(20:0)ME2315001.061.130.861.04
FA(20:3 N3)ME2315031.011.150.891.03
FA(17:0)ME2314920.900.931.061.10
FA(18:0)ME2314940.810.971.061.14
FA(20:5)ME2315070.871.101.001.04
FA(18:2)ME2314960.991.010.991.02
FA(20:3 N6)ME2315040.951.011.001.05
FA(20:4)ME2315060.911.041.011.05
16-HETEME2314761.010.821.121.01
FA(18:3 N3)ME2314971.050.961.050.90
FA(22:6)ME2315151.070.871.011.06
FA(18:3 N6)ME2314981.090.960.990.95
FA(22:5 N3)ME2315131.100.930.981.00
FA(16:0)ME2314901.090.950.951.05
FA(22:5 N6)ME2315141.090.960.961.02
9-HOTrEME2314581.480.850.960.46
PGFMME2314501.170.861.210.55
TXB1ME2314461.361.181.150.48
8,9-diHETrEME2314811.760.830.650.85
19,20 DiHDPAME2314771.700.710.850.79
9,10 EpOMEME2314781.690.690.840.84
12,13 EpOMEME2314791.570.660.910.90
FA(14:0)ME2314881.610.720.880.85
11,12-diHETrEME2314821.640.900.720.86
FA(16:1)ME2314911.610.810.820.83
14,15-diHETrEME2314831.580.820.820.87
5-HETEME2314571.570.810.840.84
6k PGF1aME2314431.890.680.780.84
9-HODEME2314711.710.780.850.69
13-HODEME2314611.780.720.820.74
15-HETEME2314601.780.720.820.72
12,13 diHOMEME2314851.770.670.880.71
15-HETrEME2314631.780.670.860.70
9-oxoODEME2314731.320.650.961.10
5,6-diHETrEME2314801.340.810.781.28
FA(20:1)ME2315011.220.820.871.18
13-oxoODEME2314741.390.511.000.83
5-HETrEME2314591.430.621.000.68
FA(20:3 N9)ME2315051.490.790.890.88
8-HETEME2314641.410.820.840.89
FA(17:1)ME2314931.430.870.850.92
FA(15:0)ME2314891.330.810.930.95
FA(20:2)ME2315021.380.790.861.05
9,10 diHOMEME2314841.390.831.020.70
8-HETrEME2314661.240.781.080.84
dhk PGF2aME2314471.320.760.980.84
LTE4ME2314561.640.280.31NA
tetranor 12-HETEME2314512.080.610.720.62
20cooh AAME2314862.240.720.580.65
PGA2ME2314542.080.870.550.56

Factors:

F1Diagnosis:Cirrhosis
F2Diagnosis:NASH
F3Diagnosis:Normal
F4Diagnosis:Steatosis
Data matrix
  logo